Usefulness of a Gentle and Short Hemostasis Using the Transradial Band Device after Transradial Access for Percutaneous Coronary Angiography and Interventions to Reduce the Radial Artery Occlusion Rate (from the Prospective and Randomized CRASOC I, II, and III Studies)

Incidence of hemorrhagic complications with use of a radial compression device: a cohort study

“…In a recent study, were evaluated three different intensities and compression periods. The results showed that a short period of 90 minutes of compression and the injection of less air than recommended (10 ml) were sufficient for hemostasis (18) .…”

Impact of sheath size and hemostasis time on radial artery patency after transradial coronary angiography and intervention in Japanese and non‐Japanese patients: A substudy from RAP and BEAT (Radial Artery Patency and Bleeding, Efficacy, Adverse evenT) randomized multicenter trial

“…RAO versus 9.4% when applying 13 cc of air and 4 hr of compression [17]. In our large population of Japanese patients, the combination of smaller radial arteries and longer hemostasis time has likely contributed to the higher rate of RAO observed with the GSS6Fr.…”

“…In support of this argument, Edris et al have recently shown in a non‐randomized study the benefit of applying a simple rapid deflation technique (minimal pressure applied in the TR Band 15 min after sheath removal, mean final TR band volume = 8.1 ± 2 cc), leading to a very high rate of patent hemostasis and a low rate of early RAO, as compared to a standard deflation technique (2% vs. 14.5%, P = 0.005) . In another recent trial that has included pooled data from 3,616 patients randomized to three consecutive protocols, the rate of RAO was markedly reduced when hemostatic compression was soft (10 cc of air in the TR Band) and short (1.5 hr), resulting in a 2.3% rate of RAO versus 9.4% when applying 13 cc of air and 4 hr of compression . In our large population of Japanese patients, the combination of smaller radial arteries and longer hemostasis time has likely contributed to the higher rate of RAO observed with the GSS6Fr.…”

Ankaferd blood stopper as a new strategy to avoid early complications after transradial procedures: A randomized clinical trial

“…Third, patients under NOAC ( n = 8) and warfarin therapy ( n = 18) alongside with 239 patients getting additional 5000 U of heparin (PCI + adhoc PCI) were not excluded from the study which may have decreased the RAO further down to 0.32% for all the study population at the end of the hemostasis. Finally, trying to relate the very low RAO rate (0.48%) to any reason in our conventional TR Band group, the study from Dangoisse et al was very enlightening . In this paper, they reached a 0.6% RAO rate at 24 h when their used only 10 cc volume of air for the TR Band patent hemostasis.…”

“…In our conventional patent hemostasis with TR Band hemostasis failure was 27.31%, and the ABS group had approximately three times less bleeding rate (9.40%, P < 0,001) compared to the other two groups. Since re‐bleeding/compression regarded as a manageable issue and its incidence ranges from 1% to 18.4% with conventional patent hemostasis, 9.40% re‐bleeding with ABS seems highly acceptable considering the 0% RAO rate achieved in short and long term. Besides, knowing the predictors of bleeding we may have the chance to further decrease the re‐bleeding rate with ABS by simply increasing the compression time a bit in this risky population.…”